Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
As of February 2026, both compounds have been reclassified as Category 1 peptides, meaning they may be compounded by licensed compounding pharmacies under a physician prescription
Product-specific reports Primary Current batch report Multi-component verified Batch PP2601 Tested size 10mg Laboratory Research Use Only
among 6 LFC outcome estimates, 5 showed significant reductions
What to Expect Individual responses vary depending on skin type, baseline pigmentation, and sun exposure
BAF53a is a potential prognostic biomarker and promotes invasion and epithelial-mesenchymal transition of glioma cells
US$ 21.21
US$ 24.53
US$ 25.47
